The zoonotic pathogen Leptospira interrogans mitigates environmental stress through cyclic-di-GMP-controlled biofilm production.


Journal

NPJ biofilms and microbiomes
ISSN: 2055-5008
Titre abrégé: NPJ Biofilms Microbiomes
Pays: United States
ID NLM: 101666944

Informations de publication

Date de publication:
12 06 2020
Historique:
received: 02 03 2020
accepted: 14 05 2020
entrez: 14 6 2020
pubmed: 14 6 2020
medline: 23 3 2021
Statut: epublish

Résumé

The zoonotic bacterium Leptospira interrogans is the aetiological agent of leptospirosis, a re-emerging infectious disease that is a growing public health concern. Most human cases of leptospirosis result from environmental infection. Biofilm formation and its contribution to the persistence of virulent leptospires in the environment or in the host have scarcely been addressed. Here, we examined spatial and time-domain changes in biofilm production by L. interrogans. Our observations showed that biofilm formation in L. interrogans is a highly dynamic process and leads to a polarized architecture. We notably found that the biofilm matrix is composed of extracellular DNA, which enhances the biofilm's cohesiveness. By studying L. interrogans mutants with defective diguanylate cyclase and phosphodiesterase genes, we show that biofilm production is regulated by intracellular levels of bis-(3'-5')-cyclic dimeric guanosine monophosphate (c-di-GMP) and underpins the bacterium's ability to withstand a wide variety of simulated environmental stresses. Our present results show how the c-di-GMP pathway regulates biofilm formation by L. interrogans, provide insights into the environmental persistence of L. interrogans and, more generally, highlight leptospirosis as an environment-borne threat to human health.

Identifiants

pubmed: 32532998
doi: 10.1038/s41522-020-0134-1
pii: 10.1038/s41522-020-0134-1
pmc: PMC7293261
doi:

Substances chimiques

Bacterial Proteins 0
Escherichia coli Proteins 0
bis(3',5')-cyclic diguanylic acid 61093-23-0
Phosphoric Diester Hydrolases EC 3.1.4.-
Phosphorus-Oxygen Lyases EC 4.6.-
diguanylate cyclase EC 4.6.1.-
Cyclic GMP H2D2X058MU

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

24

Références

Bharti, A. R. et al. Leptospirosis: a zoonotic disease of global importance. Lancet Infect. Dis. 3, 757–771 (2003).
pubmed: 14652202
Costa, F. et al. Global morbidity and mortality of leptospirosis: a systematic review. PLoS Negl. Trop. Dis. 9, e0003898 (2015).
pubmed: 26379143 pmcid: 4574773
Adler, B. & de la Pena Moctezuma, A. Leptospira and leptospirosis. Vet. Microbiol 140, 287–296 (2009).
pubmed: 19345023
Thibeaux, R. et al. Seeking the environmental source of leptospirosis reveals durable bacterial viability in river soils. PLoS Negl. Trop. Dis. 11, e0005414 (2017).
pubmed: 28241042 pmcid: 5344526
Andre-Fontaine, G., Aviat, F. & Thorin, C. Waterborne leptospirosis: survival and preservation of the virulence of pathogenic leptospira spp. in fresh water. Curr. Microbiol. 71, 136–142 (2015).
pubmed: 26003629
Goarant, C. et al. in Global Water Pathogen Project (eds. Rose, J. B. & Jiménez-Cisneros, B.) (Michigan State University, E. Lansing, MI, UNESCO, 2019).
Ristow, P. et al. Biofilm formation by saprophytic and pathogenic leptospires. Microbiology 154, 1309–1317 (2008).
pubmed: 18451039
Brihuega, B., Samartino, L., Auteri, C., Venzano, A. & Caimi, K. In vivo cell aggregations of a recent swine biofilm-forming isolate of Leptospira interrogans strain from Argentina. Rev. Argent. Microbiol. 44, 138–143 (2012).
pubmed: 23102459
Vinod Kumar, K., Lall, C., Raj, R. V., Vedhagiri, K. & Vijayachari, P. Molecular detection of pathogenic leptospiral protein encoding gene (lipL32) in environmental aquatic biofilms. Lett. Appl Microbiol. 62, 311–315 (2016).
pubmed: 26643849
Singh, R. et al. Microbial diversity of biofilms in dental unit water systems. Appl Environ. Microbiol. 69, 3412–3420 (2003).
pubmed: 12788744 pmcid: 161485
Huang, K., Zhang, X. X., Shi, P., Wu, B. & Ren, H. A comprehensive insight into bacterial virulence in drinking water using 454 pyrosequencing and Illumina high-throughput sequencing. Ecotoxicol. Environ. Saf. 109, 15–21 (2014).
pubmed: 25129220
Monahan, A., Callanan, J. & Nally, J. Host-pathogen interactions in the kidney during chronic leptospirosis. Vet. Pathol. 46, 792–799 (2009).
pubmed: 19429975
Sterling, C. R. & Thiermann, A. B. Urban rats as chronic carriers of leptospirosis: an ultrastructural investigation. Vet. Pathol. 18, 628–637 (1981).
pubmed: 7281461
Werts, C. Interaction of Leptospira with the innate immune system. Curr. Top. Microbiol Immunol. 415, 163–187 (2018).
pubmed: 29038956
Hall-Stoodley, L., Costerton, J. W. & Stoodley, P. Bacterial biofilms: from the natural environment to infectious diseases. Nat. Rev. Microbiol. 2, 95–108 (2004).
pubmed: 15040259
Le Magrex-Debar, E., Lemoine, J., Gelle, M. P., Jacquelin, L. F. & Choisy, C. Evaluation of biohazards in dehydrated biofilms on foodstuff packaging. Int J. Food Microbiol. 55, 239–243 (2000).
pubmed: 10791750
McNeill, K. & Hamilton, I. R. Acid tolerance response of biofilm cells of Streptococcus mutans. FEMS Microbiol Lett. 221, 25–30 (2003).
pubmed: 12694906
Espeland, E. M. & Wetzel, R. G. Complexation, stabilization, and UV photolysis of extracellular and surface-bound glucosidase and alkaline phosphatase: implications for biofilm microbiota. Micro. Ecol. 42, 572–585 (2001).
Stewart, P. S. & Costerton, J. W. Antibiotic resistance of bacteria in biofilms. Lancet 358, 135–138 (2001).
pubmed: 11463434
Teitzel, G. M. & Parsek, M. R. Heavy metal resistance of biofilm and planktonic Pseudomonas aeruginosa. Appl Environ. Microbiol. 69, 2313–2320 (2003).
pubmed: 12676715 pmcid: 154819
Flemming, H. C. & Wingender, J. The biofilm matrix. Nat. Rev. Microbiol 8, 623–633 (2010).
pubmed: 20676145
Hengge, R. Principles of c-di-GMP signalling in bacteria. Nat. Rev. Microbiol 7, 263–273 (2009).
pubmed: 19287449
Boyd, C. D. & O’Toole, G. A. Second messenger regulation of biofilm formation: breakthroughs in understanding c-di-GMP effector systems. Annu Rev. Cell Dev. Biol. 28, 439–462 (2012).
pubmed: 23057745 pmcid: 4936406
Jenal, U., Reinders, A. & Lori, C. Cyclic di-GMP: second messenger extraordinaire. Nat. Rev. Microbiol 15, 271–284 (2017).
pubmed: 28163311
Ryjenkov, D. A., Tarutina, M., Moskvin, O. V. & Gomelsky, M. Cyclic diguanylate is a ubiquitous signaling molecule in bacteria: insights into biochemistry of the GGDEF protein domain. J. Bacteriol. 187, 1792–1798 (2005).
pubmed: 15716451 pmcid: 1064016
Schmidt, A. J., Ryjenkov, D. A. & Gomelsky, M. The ubiquitous protein domain EAL is a cyclic diguanylate-specific phosphodiesterase: enzymatically active and inactive EAL domains. J. Bacteriol. 187, 4774–4781 (2005).
pubmed: 15995192 pmcid: 1169503
Romling, U., Galperin, M. Y. & Gomelsky, M. Cyclic di-GMP: the first 25 years of a universal bacterial second messenger. Microbiol Mol. Biol. Rev. 77, 1–52 (2013).
pubmed: 23471616 pmcid: 3591986
Simm, R., Morr, M., Kader, A., Nimtz, M. & Romling, U. GGDEF and EAL domains inversely regulate cyclic di-GMP levels and transition from sessility to motility. Mol. Microbiol 53, 1123–1134 (2004).
pubmed: 15306016
da Costa Vasconcelos, F. N. et al. Structural and enzymatic characterization of a cAMP-dependent diguanylate cyclase from pathogenic leptospira species. J. Mol. Biol. 429, 2337–2352 (2017).
pubmed: 28601495
Xiao, G. et al. Identification and characterization of c-di-GMP metabolic enzymes of Leptospira interrogans and c-di-GMP fluctuations after thermal shift and infection. Front Microbiol. 9, 764 (2018).
pubmed: 29755425 pmcid: 5932348
Seshasayee, A. S., Fraser, G. M. & Luscombe, N. M. Comparative genomics of cyclic-di-GMP signalling in bacteria: post-translational regulation and catalytic activity. Nucleic Acids Res. 38, 5970–5981 (2010).
pubmed: 20483912 pmcid: 2952852
Beenken, K. E. et al. Global gene expression in Staphylococcus aureus biofilms. J. Bacteriol. 186, 4665–4684 (2004).
pubmed: 15231800 pmcid: 438561
Mueller, R. S. et al. Vibrio cholerae strains possess multiple strategies for abiotic and biotic surface colonization. J. Bacteriol. 189, 5348–5360 (2007).
pubmed: 17496082 pmcid: 1951843
Tahara, H. et al. The mechanism of two-phase motility in the spirochete <em>Leptospira</em>: Swimming and crawling. Sci. Adv. 4, eaar7975 (2018).
pubmed: 29854948 pmcid: 5976277
Stewart, P. S. Diffusion in biofilms. J. Bacteriol. 185, 1485–1491 (2003).
pubmed: 12591863 pmcid: 148055
Berlanga, M. & Guerrero, R. Living together in biofilms: the microbial cell factory and its biotechnological implications. Micro. Cell Fact. 15, 165 (2016).
Hung, C. et al. Escherichia coli biofilms have an organized and complex extracellular matrix structure. MBio 4, e00645–13 (2013).
pubmed: 24023384 pmcid: 3774191
Erskine, E., MacPhee, C. E. & Stanley-Wall, N. R. Functional amyloid and other protein fibers in the biofilm matrix. J. Mol. Biol. 430, 3642–3656 (2018).
pubmed: 30098341 pmcid: 6173796
Whitchurch, C. B., Tolker-Nielsen, T., Ragas, P. C. & Mattick, J. S. Extracellular DNA required for bacterial biofilm formation. Science 295, 1487 (2002).
pubmed: 11859186
Montanaro, L. et al. Extracellular DNA in biofilms. Int J. Artif. Organs 34, 824–831 (2011).
pubmed: 22094562
Picardeau, M. et al. Genome sequence of the saprophyte Leptospira biflexa provides insights into the evolution of Leptospira and the pathogenesis of leptospirosis. PLoS ONE 3, e1607 (2008).
pubmed: 18270594 pmcid: 2229662
Grassmann, A. A. et al. Discovery of novel leptospirosis vaccine candidates using reverse and structural vaccinology. Front Immunol. 8, 463 (2017).
pubmed: 28496441 pmcid: 5406399
Iraola, G. et al. Transcriptome sequencing reveals wide expression reprogramming of basal and unknown genes in leptospira biflexa biofilms. mSphere 1, e00042–16 (2016).
pubmed: 27303713 pmcid: 4863578
Ratet, G. et al. Live imaging of bioluminescent Leptospira interrogans in mice reveals renal colonization as a stealth escape from the blood defenses and antibiotics. PLoS Negl. Trop. Dis. 8, e3359 (2014).
pubmed: 25474719 pmcid: 4256284
Hufnagel, D. A., Depas, W. H. & Chapman, M. R. The biology of the Escherichia coli extracellular matrix. Microbiol. Spectr. 3, 249–267 (2015).
Opoku-Temeng, C., Zhou, J., Zheng, Y., Su, J. & Sintim, H. O. Cyclic dinucleotide (c-di-GMP, c-di-AMP, and cGAMP) signalings have come of age to be inhibited by small molecules. Chem. Commun. (Camb.) 52, 9327–9342 (2016).
Koo, H., Allan, R. N., Howlin, R. P., Stoodley, P. & Hall-Stoodley, L. Targeting microbial biofilms: current and prospective therapeutic strategies. Nat. Rev. Microbiol. 15, 740–755 (2017).
pubmed: 28944770 pmcid: 5685531
Johnson, R. C. & Rogers, P. Differentiation of pathogenic and saprophytic leptospires with 8-azaguanine. J. Bacteriol. 88, 1618–1623 (1964).
pubmed: 14244050 pmcid: 277463
Ellinghausen, H. C. Jr. & McCullough, W. G. Nutrition of Leptospira Pomona and growth of 13 other serotypes: fractionation of oleic albumin complex and a medium of bovine albumin and polysorbate 80. Am. J. Vet. Res. 26, 45–51 (1965).
pubmed: 14266934
Bourhy, P., Louvel, H., Saint Girons, I. & Picardeau, M. Random insertional mutagenesis of Leptospira interrogans, the agent of leptospirosis, using a mariner transposon. J. Bacteriol. 187, 3255–3258 (2005).
pubmed: 15838053 pmcid: 1082815
Murray, G. L. et al. Genome-wide transposon mutagenesis in pathogenic Leptospira spp. Infect. Immun. 77, 810–816 (2009).
pubmed: 19047402
Pappas, C. J., Benaroudj, N. & Picardeau, M. A replicative plasmid vector allows efficient complementation of pathogenic Leptospira strains. Appl Environ. Microbiol. 81, 3176–3181 (2015).
pubmed: 25724960 pmcid: 4393447
Schindelin, J. et al. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9, 676–682 (2012).
Braet, F., De Zanger, R. & Wisse, E. Drying cells for SEM, AFM and TEM by hexamethyldisilazane: a study on hepatic endothelial cells. J. Microsc 186, 84–87 (1997).
pubmed: 9159923
Burhenne, H. & Kaever, V. Quantification of cyclic dinucleotides by reversed-phase LC-MS/MS. Methods Mol. Biol. 1016, 27–37 (2013).
pubmed: 23681570
Merien, F., Amouriaux, P., Perolat, P., Baranton, G. & Saint Girons, I. Polymerase chain reaction for detection of Leptospira spp. in clinical samples. J. Clin. Microbiol. 30, 2219–2224 (1992).
pubmed: 1400983 pmcid: 265482

Auteurs

Roman Thibeaux (R)

Institut Pasteur de Nouvelle-Calédonie, Unité de Recherche et d'Expertise sur la Leptospirose, Noumea, New Caledonia. rthibeaux@pasteur.nc.

Marie-Estelle Soupé-Gilbert (ME)

Institut Pasteur de Nouvelle-Calédonie, Unité de Recherche et d'Expertise sur la Leptospirose, Noumea, New Caledonia.

Malia Kainiu (M)

Institut Pasteur de Nouvelle-Calédonie, Unité de Recherche et d'Expertise sur la Leptospirose, Noumea, New Caledonia.

Dominique Girault (D)

Institut Pasteur de Nouvelle-Calédonie, Unité de Recherche et d'Expertise sur la Leptospirose, Noumea, New Caledonia.

Emilie Bierque (E)

Institut Pasteur de Nouvelle-Calédonie, Unité de Recherche et d'Expertise sur la Leptospirose, Noumea, New Caledonia.

Julien Fernandes (J)

Institut Pasteur, UTechS PBI, Centre de Ressources et Recherches Technologiques (C2RT), Paris, France.

Heike Bähre (H)

Hannover Medical School, Research Core Unit Metabolomics, Hannover, Germany.

Anthony Douyère (A)

Université de la Nouvelle-Calédonie, Institut des Sciences Exactes et Appliquées, Plateau MET/MEB, Noumea, New Caledonia.

Nicolas Eskenazi (N)

École Supérieure de Physique et de Chimie Industrielles de la ville de Paris, Spectrométrie de Masse Biologique et Protéomique, CNRS, Université Paris-Sciences-et-Lettres, Paris, France.

Joëlle Vinh (J)

École Supérieure de Physique et de Chimie Industrielles de la ville de Paris, Spectrométrie de Masse Biologique et Protéomique, CNRS, Université Paris-Sciences-et-Lettres, Paris, France.

Mathieu Picardeau (M)

Institut Pasteur, Unité Biologie des Spirochètes, Paris, France.

Cyrille Goarant (C)

Institut Pasteur de Nouvelle-Calédonie, Unité de Recherche et d'Expertise sur la Leptospirose, Noumea, New Caledonia. cgoarant@pasteur.nc.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH